Breaking

Medtronic unveils software development hub for Galway

Fionnuala Mannion and Shane Cooney, R&D Engineering Managers at Medtronic Parkmore, with the new PCS technology.  Photo: Andrew Downes XPOSUREplaceholder image
Fionnuala Mannion and Shane Cooney, R&D Engineering Managers at Medtronic Parkmore, with the new PCS technology. Photo: Andrew Downes XPOSURE | ©Andrew Downes, xposure

One of Galway’s biggest employers heralded the arrival of what could be a whole new chapter for the global MedTech giant with the potential to hugely enhance cardiac care in the process.

Medtronic announced the establishment of its new European software development hub in Galway for its Patient Care Systems function.

The site will serve as a global Centre of Excellence for cardiac digital health, supporting the development of advanced software solutions that enhance care for patients with implanted cardiac devices.

The brief is to focus on the software used to programme pacemakers – as well as implantable defibrillators and other devices – as they are initially inserted into the patient during surgery.

The devices will them be able to provide ongoing data for both patients and medical staff – accelerating the delivery of connected data-driven care solutions.

The group’s PCS team will initially employ 85 people at its Parkmore facility – with that number expected to grow over the next three years, reflecting sustained investment in digital health innovation.

Medtronic’s decision to expand its PCS function in Galway brings their total investment in Ireland to approximately €11 billion over the last 40 years – including €1.2 billion in research and development.

The announcement was made in Galway this (Wednesday) morning in the presence of Taoiseach Micheál Martin.

It marks a strategic investment in digital innovation in the West of Ireland, with commensurate growth expected over the next three years.

Taoiseach Micheál Martin

PCS Vice-President Alex Mann said that the systems software hub would be a key part of Medtronic’s global organisation.

“This investment reflects our confidence in the exceptional talent, strong engineering heritage and collaborative ecosystem across the West of Ireland,” he said.

“PCS in Galway represents far more than an expansion of our footprint. Our vision is to build an enduring software capability that advances cardiac care, accelerates innovation and delivers solutions that empower clinicians and improves patient outcomes worldwide,” he added.

Taoiseach Micheál Martin said that Ireland’s position as a global leader in MedTech and digital health was built on sustained investment in innovation and people.

“The immediate creation of 85 high-value jobs will support long-term economic growth in the West of Ireland and provide exciting new career opportunities for local people, including graduates of local universities,” he said.

“It marks a strategic investment in digital innovation in the West of Ireland, with commensurate growth expected over the next three years,” he added.

Roles at the Galway site include leadership, software engineering, and systems reliability positions. The site will focus on developing cloud-based platforms and clinical software that connect devices, clinicians, and patients in real time.

Patient Care Systems (PCS) is Medtronic’s digital backbone for cardiac care, connecting patients, clinicians, and life-saving cardiac devices across the entire care journey—from the initial implant through a lifetime of follow-up.

PCS develops and operates the platforms that enable device programming, remote monitoring, data delivery, and clinical insights at a global scale, reducing clinician in-clinic burden while improving reliability, access, and outcomes.

Globally, over three million patients rely on these systems to stay connected to their care teams.

By combining software, connected devices, data, and services, PCS transforms episodic cardiac treatment into continuous, connected care that helps clinicians work more efficiently and helps patients live with greater confidence.

Powered by
Follow us
© 2026 Formpress Publishing LTD. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice